Laboratory and clinical characteristics of Staphylococcus lugdunensis prosthetic joint infections

Journal of Clinical Microbiology

Volumn 48, Issue 5, 2010, Pages 1600-1603

  Shah, Neel B ^a,b   Osmon, Douglas R ^a   Fadel, Hind ^a   Patel, Robin ^a   Kohner, Peggy C ^a   Steckelberg, James M ^a   Mabry, Tad ^a   Berbari, Elie F ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFAZOLIN; CEFTRIAXONE; COTRIMOXAZOLE; GENTAMICIN; MINOCYCLINE; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGAR DILUTION; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HIP PROSTHESIS; HUMAN; KNEE PROSTHESIS; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; PROSTHESIS INFECTION; SEX RATIO; STAPHYLOCOCCUS LUGDUNENSIS; SURVIVAL RATE; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHRITIS; BETA-LACTAMASES; BETA-LACTAMS; COHORT STUDIES; FEMALE; GENES, BACTERIAL; HUMANS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINNESOTA; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TREATMENT OUTCOME; VANCOMYCIN;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS LUGDUNENSIS;

EID: 77951554900     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01769-09     Document Type: Article

References (23)

1. Bolon, M. K., M. Morlote, S. G. Weber, B. Koplan, Y. Carmeli, and S. B. Wright. 2004. Glycopeptides are no more effective than β-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin. Infect. Dis. 38:1357-1363.
2. Reference deleted.
3. Finkelstein, R., G. Rabino, T. Mashiah, Y. Bar-El, Z. Adler, V. Kertzman, O. Cohen, and S. Milo. 2002. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J. Thorac. Cardiovasc. Surg. 123:326-332.
4. Fleurette, J., M. Bes, Y. Brun, J. Freney, M. Coulet, M. E. Reverdy, and J. Etienne 1989. Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: bacterial characteristics and susceptibility to antimicrobial agents. Res. Microbiol. 140:107-118.
5. Reference deleted.
6. Freney, J., Y. Brun, M. Bes, H. Meugnier, F. Grimont, P. Grimont, C. Nervi, and J. Fleurette. 1988. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int. J. Syst. Bacteriol. 38:168-172.
7. Herchline, T. E., J. Barnishan, L. W. Ayers, and R. J. Fass. 1990. Penicillinase production and in vitro susceptibilities of Staphylococcus lugdunensis. Antimicrob. Agents Chemother. 34:2434-2435.
8. Herchiline, T. E., and L. W. Ayers. 1991. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation and infection. J. Clin. Microbiol. 29:419-421.
9. Hussain, Z., L. Stoakes, V. Massey, D. Diagre, V. Fitzgerald, S. El Sayed, and R. Lannigan. 2000. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J. Clin. Microbiol. 38:752-754.
10. Ling, M. L., and M. Yeo. 2000. Staphylococcus lugdunensis: report of first case of skin and soft tissue infection in Singapore. Singapore Med. J. 41:177-178.
11. Monsen, T., H. Abd, K. Leonardsson, H. Edebro, and J. Wistrom. 2002. Prediction of mecA-positive coagulase-negative staphylococci: assessment of different phenotypic methods, breakpoints, culture media and culture conditions. J. Antimicrob. Chemother. 49:197-200.
12. Murdoch, D. R., R. J. Everts, S. T. Chambers, and I. A. Cowan. 1996. Vertebral osteomyelitis due to Staphylococcus lugdunensis. J. Clin. Microbiol. 34:993-994.
13. Patel, R., K. E. Piper, M. S. Rouse, J. R. Uhl, F. R. Cockerill III, and J. M. Steckelberg. 2000. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20-year experience. J. Clin. Microbiol. 38:4262-4263.
14. Perazzi, B., M. R. Fermepin, A. Malimovka, S. D. Garcia, M. Orgambide, C. A. Vay, R. de Torres, and A. M. R. Famiglietti. 2006. Accuracy of cefoxitin disk testing for characterization of oxacillin resistance mediated by penicillin-binding protein 2a in coagulase-negative staphylococci. J. Clin. Microbiol. 44:3634-3639.
15. Sampathkumar, P., D. R. Osmon, and F. R. Cockerill III. 2000. Prosthetic joint infection due to Staphylococcus lugdunensis. Mayo Clinic Proc. 75:511-512.
16. Seenivasan, M. H., and V. L Yu. 2003. Staphylococcus lugdunensis endocarditis: the hidden peril of coagulase-negative staphylococcus in blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 22:489-491.
17. Shuttleworth, R., and W. D. Colby. 1992. Staphylococcus lugdunensis endocarditis. J. Clin. Microbiol. 30:1948-1952.
18. Tan, T. Y., S. Y. Ng, and J. He. 2008. Microbiological characteristics, presumptive identification, and antibiotic susceptibilities of Staphylococcus lugdunensis. J. Clin. Microbiol. 46:2393-2395.
19. Tsukayama, D. T., V. M. Goldberg, and R. Kyle. 2003. Diagnosis and management of infection after total knee arthroplasty. J. Bone Joint Surg. Am. 85:S75-S80.
20. Reference deleted.
21. Van der Mee-Marquet, N., A. Achard, L. Mereghetti, A. Danton, M. Minier, and R. Quentin. 2003. Staphylococcus lugdunensis infections: high frequency of inguinal area carriage. J. Clin. Microbiol. 41:1404-1409.
22. Reference deleted.
23. Wood, C. A., and R. M. Wisniewski. 1994. Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus. Antimicrob. Agents Chemother. 38:1023-1026.